Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Clinical and serological findings of Madariaga and Venezuelan equine encephalitis viral infections: A follow-up study five years after an outbreak in Panama

View ORCID ProfileJean-Paul Carrera, Yaneth Pittí, Juan C. Molares-Matrínez, Eric Casal, Reneé Pereyra-Elias, Lisseth Saenz, Isela Guerrero, Josefrancisco Galué, Fatima Rodriguez-Alvarez, Carmela Jackman, Juan Miguel Pascale, Blas Armien, Scott C. Weaver, Christl A. Donnelly, Amy Y. Vittor
doi: https://doi.org/10.1101/2020.02.13.20022798
Jean-Paul Carrera
1Department of Zoology, University of Oxford, Oxford, United Kingdom
2Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-Paul Carrera
  • For correspondence: jean.carrera{at}zoo.ox.ac.uk jpcarrera{at}gorgas.gob.pa Amy.Vittor{at}medicine.ufl.edu
Yaneth Pittí
2Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan C. Molares-Matrínez
2Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Casal
2Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reneé Pereyra-Elias
3National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisseth Saenz
2Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isela Guerrero
2Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josefrancisco Galué
2Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatima Rodriguez-Alvarez
2Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmela Jackman
4Departments of Epidemiology, Ministry of Health, Panama, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Miguel Pascale
5Clinical Research Unit, Gorgas Memorial Institute of health studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blas Armien
6Department of Research in Emerging and Zoonotic Diseases, Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott C. Weaver
7Institute for Human Infection and Immunity, Department of Microbiology and Immunology, Department of Pathology, and World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christl A. Donnelly
8MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
9Department of Statistics, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Y. Vittor
10Department of Medicine, Division of Infectious Disease and Global Medicine, University of Florida, Gainesville, Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jean.carrera{at}zoo.ox.ac.uk jpcarrera{at}gorgas.gob.pa Amy.Vittor{at}medicine.ufl.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Human cases of Madariaga virus (MADV) infection were first detected during an outbreak in 2010 in eastern Panama, where Venezuelan equine encephalitis virus (VEEV) also circulates. Little is known about the long-term consequences of either alphavirus infection.

Methods A follow-up study of the 2010 outbreak was undertaken in 2015. An additional survey was carried out two weeks after a separate 2017 alphavirus outbreak in a neighboring population in eastern Panama. Serological studies and statistical analysis were undertaken in both populations.

Results Amongst the originally alphavirus-seronegative subjects (n=35 of 65), seroconversion was observed at a rate of 14.3% (95% CI: 4.8%-30.3%) for MADV and 8.6% (95% CI: 1.8%-23.1%) for VEEV over 5 years. Amongst the originally MADV seropositive subjects (n=14 of 65), VEEV seroconversion occurred in 35.7% (95% CI: 12.8%-64.9%). In the VEEV seropositive subjects (n=16 of 65), MADV seroconversion occurred in 6.3% (95% CI: 0.2%-30.2%). MADV seroreversion was observed in 14.3% (95% CI: 1.8%-42.8%) of those originally seropositive in 2010. VEEV seroconversion in the baseline MADV-seropositive subjects was significantly higher than in alphavirus-negative subjects. In the population sampled in 2017, MADV and VEEV seroprevalence was 13.2% and 16.8%, respectively. Memory loss, insomnia, irritability and seizures were reported significantly more frequently in alphavirus-seropositive subjects than in seronegative.

Conclusions High rates of 5-year seroconversions to MADV and VEEV suggest continuous circulation of both viruses in Panama. Enhanced susceptibility may be conferred by MADV towards VEEV. We provide evidence of persistent neurologic symptoms up to 5 years following MADV and VEEV exposure.

summary We estimate seroconversion rates over a 5-year period to Madariaga (MADV) and Venezuelan equine encephalitis (VEEV) alphaviruses in Panama. Individuals with MADV antibodies seroconverted to VEEV at a rate greater than individuals who were alphavirus-negative at baseline. This was not observed in individuals with VEEV antibodies, suggesting asymmetric cross-immunity. Neurological sequelae were reported more frequently by MADV and/or VEEV seropositive-versus seronegative subjects.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Neglected Diseases Grant from the Ministry of Economy and Finance of Panama to JMP [grant number 1.11.1.3.703.01.55.120] and by the World Reference Center for Emerging Viruses and Arboviruses, NIH [grant number AI120942]. JPC is funded by the Clarendon Scholarship from University of Oxford and Lincoln-Kingsgate Scholarship from Lincoln College, University of Oxford [grant number SFF1920_CB2_MPLS_1293647]. CAD acknowledges the MRC Centre, which is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the information is included in the manuscript. The authors may be contacted at Gorgas Memorial Institute (GMI) for additional information. All information is included in the manuscript. Our epidemiological data cannot be made publicly available for legal reasons (e.g., public availability would compromise patient privacy) by Law 68, 2003 (http://200.46. 254.138/APPS/LEGISPAN/PDF_NORMAS/2000/ 2003/2003_531_2443.PDF).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 17, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clinical and serological findings of Madariaga and Venezuelan equine encephalitis viral infections: A follow-up study five years after an outbreak in Panama
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical and serological findings of Madariaga and Venezuelan equine encephalitis viral infections: A follow-up study five years after an outbreak in Panama
Jean-Paul Carrera, Yaneth Pittí, Juan C. Molares-Matrínez, Eric Casal, Reneé Pereyra-Elias, Lisseth Saenz, Isela Guerrero, Josefrancisco Galué, Fatima Rodriguez-Alvarez, Carmela Jackman, Juan Miguel Pascale, Blas Armien, Scott C. Weaver, Christl A. Donnelly, Amy Y. Vittor
medRxiv 2020.02.13.20022798; doi: https://doi.org/10.1101/2020.02.13.20022798
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Clinical and serological findings of Madariaga and Venezuelan equine encephalitis viral infections: A follow-up study five years after an outbreak in Panama
Jean-Paul Carrera, Yaneth Pittí, Juan C. Molares-Matrínez, Eric Casal, Reneé Pereyra-Elias, Lisseth Saenz, Isela Guerrero, Josefrancisco Galué, Fatima Rodriguez-Alvarez, Carmela Jackman, Juan Miguel Pascale, Blas Armien, Scott C. Weaver, Christl A. Donnelly, Amy Y. Vittor
medRxiv 2020.02.13.20022798; doi: https://doi.org/10.1101/2020.02.13.20022798

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)